RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.
- DOI
- 10.1016/j.biopha.2016.01.045
- Published
- 2016 Apr
- Container
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2016.01.045,
title = {RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.},
author = {Li B and Lu Y and Wang H and Han X and Mao J and Li J and Yu L and Wang B and Fan S and Yu X and Song B},
year = {2016},
journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
doi = {10.1016/j.biopha.2016.01.045},
url = {https://doi.org/10.1016/j.biopha.2016.01.045}
}RIS
TY - JOUR TI - RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway. AU - Li B AU - Lu Y AU - Wang H AU - Han X AU - Mao J AU - Li J AU - Yu L AU - Wang B AU - Fan S AU - Yu X AU - Song B PY - 2016 JO - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie DO - 10.1016/j.biopha.2016.01.045 UR - https://doi.org/10.1016/j.biopha.2016.01.045 ER -
APA
B, L., Y, L., H, W., X, H., J, M., J, L., L, Y., B, W., S, F., X, Y., & B, S. (2016). RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2016.01.045
Source records
- pubmed · retrieved 2026-09-25T04:14:38.617Z